Go to deals
Healthcare

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Medicija is a leading fertility services provider in Lithuania with a growing offering across multiple specialist consultation areas. It operates three modern clinics in Vilnius, Kaunas and Klaipėda.

Founded 25 years ago by five family doctors, Saulės Šeimos Medicinos Centras is the largest primary healthcare provider in the Kaunas region, operating four state-of-the-art clinics in the city. The company serves approximately 28,000 registered patients and employs 170 people.

Oaklins’ team in Lithuania acted as the financial advisor to Medicija in the acquisition. This transaction marks the team’s third engagement with Medicija, strengthening the company’s position in the Lithuanian healthcare services market and laying a solid foundation for future growth.

Parties

Talk to the deal team

Natalja Titova

Associate Partner
Vilnius, Lithuania
Oaklins Baltics

Related deals

Quimpharma has completed the divestiture of a product portfolio to Megalabs
Healthcare

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Learn more
IXICO has completed a fundraising
Healthcare

IXICO has completed a fundraising

IXICO plc, a specialist in AI-driven neuroimaging analytics, has completed a US$13.5 million gross capital raise. The funds will be used to support the company’s tech bio strategy, which will see IXICO partner its platform to maximize its potential.

Learn more
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Healthcare

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval

Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.

Learn more